ARCHIVES

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

States Join Suit Alleging Amgen Offered Illegal Kickback To Doctors For Aranesp

November 6, 2009

FDA To Regulate Products From Human Cells, Tissue

March 21, 1997

Funding Opportunities.

April 12, 2002

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

In Brief: Anderson Assumes ACCC President, Enck President Elect; Reagan Reappoints Montgomery

April 11, 1986

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009